Work

Rituximab in Primary Membranous Nephropathy: First-Line Therapy, Why Not?

Year: 2014

Type: review

Source: Nephron Clinical Practice

DOI: 10.1159/000368589

Authors: Paolo Cravedi, Giuseppe Remuzzi, Piero Ruggenenti

Institutions: Icahn School of Medicine at Mount Sinai, Mario Negri Institute for Pharmacological Research, Ospedale Papa Giovanni XXIII, Istituti di Ricovero e Cura a Carattere Scientifico

Language: English

Topic: Renal Diseases and Glomerulopathies

Subfield: Nephrology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2033965404

FWCI: 1.017

Cites: 62

Cited by: 55

Related to: 10